BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23107608)

  • 1. Pyoderma gangrenosum possibly triggered by adalimumab.
    Kikuchi N; Hiraiwa T; Ohashi T; Hanami Y; Satoh M; Takenoshita H; Yamamoto T
    Eur J Dermatol; 2012; 22(6):804-5. PubMed ID: 23107608
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon?
    Stichenwirth M; Riedl E; Pehamberger H; Tappeiner G
    Arch Dermatol; 2008 Jun; 144(6):817-8. PubMed ID: 18559788
    [No Abstract]   [Full Text] [Related]  

  • 3. Pyoderma gangrenosum induced by adalimumab in a seropositive rheumatoid arthritis patient: a paradoxical effect of adalimumab?
    Tan Y; Kavaklieva S; Wood F
    Rheumatology (Oxford); 2021 Aug; 60(8):e288-e289. PubMed ID: 33836074
    [No Abstract]   [Full Text] [Related]  

  • 4. Generalized pustulosis induced by adalimumab in a patient with rheumatoid arthritis - a therapeutic challenge.
    Kucharekova M; Winnepenninckx V; Frank J; Poblete-Gutiérrez P
    Int J Dermatol; 2008 Nov; 47 Suppl 1():25-8. PubMed ID: 18986481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palisaded neutrophilic and granulomatous dermatitis in a rheumatoid arthritis patient after treatment with adalimumab.
    Umezawa Y; Ito K; Nakagawa H
    Eur J Dermatol; 2013; 23(6):910-1. PubMed ID: 24201093
    [No Abstract]   [Full Text] [Related]  

  • 6. Adalimumab treatment for pyoderma gangrenosum.
    Heffernan MP; Anadkat MJ; Smith DI
    Arch Dermatol; 2007 Mar; 143(3):306-8. PubMed ID: 17372094
    [No Abstract]   [Full Text] [Related]  

  • 7. Adalimumab for treatment of pyoderma gangrenosum.
    Pomerantz RG; Husni ME; Mody E; Qureshi AA
    Br J Dermatol; 2007 Dec; 157(6):1274-5. PubMed ID: 17916198
    [No Abstract]   [Full Text] [Related]  

  • 8. Paradoxical reactions to targeted biological treatments: A way to treat and trigger?
    Brunasso AM; Laimer M; Massone C
    Acta Derm Venereol; 2010 Mar; 90(2):183-5. PubMed ID: 20169304
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
    Reddick CL; Singh MN; Chalmers RJ
    Dermatol Online J; 2010 Aug; 16(8):15. PubMed ID: 20804692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
    Ueharaguchi Y; Kabashima K; Sasahashi M; Matsuda A; Matubara K; Matsui M
    Int J Dermatol; 2013 May; 52(5):634-6. PubMed ID: 23590380
    [No Abstract]   [Full Text] [Related]  

  • 11. A Case of Pyoderma Gangrenosum in a Patient with Rheumatoid Arthritis Treated with Abatacept.
    Akahoshi-Ikeda M; Yoshizawa S; Motoshita J; Furue M; Takeuchi S
    Acta Derm Venereol; 2016 Aug; 96(6):822-3. PubMed ID: 26912455
    [No Abstract]   [Full Text] [Related]  

  • 12. Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis.
    Vandevyvere K; Luyten FP; Verschueren P; Lories R; Segaert S; Westhovens R
    Clin Rheumatol; 2007 Dec; 26(12):2205-2206. PubMed ID: 17876646
    [No Abstract]   [Full Text] [Related]  

  • 13. Injection site reaction to adalimumab: Positive skin test and successful rapid desensitisation.
    Bavbek S; Ataman Ş; Bankova L; Castells M
    Allergol Immunopathol (Madr); 2013; 41(3):204-6. PubMed ID: 23063342
    [No Abstract]   [Full Text] [Related]  

  • 14. Imatinib induced pyoderma gangrenosum.
    Pinato DJ; Sharma R
    J Postgrad Med; 2013; 59(3):244-5. PubMed ID: 24029213
    [No Abstract]   [Full Text] [Related]  

  • 15. Injection site reactions of adalimumab spreading on the trunk in a psoriatic arthritis patient.
    Kato Y; Kawakami Y; Yamamoto T
    J Dermatol; 2013 Nov; 40(11):931-2. PubMed ID: 24112030
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxidermia under treatment with tocilizumab for rheumatoid arthritis.
    Fechtenbaum M; Banse C; Boyard-Lasselin P; Goëb V
    Joint Bone Spine; 2015 Jan; 82(1):69-70. PubMed ID: 25048098
    [No Abstract]   [Full Text] [Related]  

  • 17. Massive pyoderma gangrenosum in a 77 year old female with Crohn's disease responsive to adalimumab.
    Lipka S; Katz S; Ginzburg L
    J Crohns Colitis; 2013 Jun; 7(5):427-8. PubMed ID: 22926276
    [No Abstract]   [Full Text] [Related]  

  • 18. Photosensitivity due to tocilizumab presenting with erythema multiforme-like lesions.
    Hamada K; Sawada Y; Yamaguchi T; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
    Eur J Dermatol; 2016 Oct; 26(5):503-504. PubMed ID: 27346710
    [No Abstract]   [Full Text] [Related]  

  • 19. [Severe pyoderma associated with rheumatoid arthritis].
    Renner R; Sticherling M
    Med Klin (Munich); 2008 Apr; 103(4):251-3. PubMed ID: 18484211
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute generalized skin eruption due to adalimumab: report of two cases.
    Dalmau J; Roé E; Corella F; García-Navarro X; Peramiquel L; Alomar A
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1105-6. PubMed ID: 17714134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.